1. Demographics 2. Targeted medical history 3. Outpatient and inpatient medications (including experimental medications, vasopressors, and neuromuscular blockade agents) 4. COVID-19 symptoms, symptom onset, and exposure history 5. Date of admission to hospital, date of admission or transfer to ICU (if applicable), and date of discharge 6. Targeted physical findings 7. Vital signs (temperature, heart and respiration rates, oxygen saturation) 8. Chest imaging findings 9. Laboratory findings a. CBC with differential b. Metabolic panel (to include serum creatinine, total bilirubin, liver function tests, and electrolytes) c. SpO2, arterial blood gas data d. PT/INR, D-dimer e. Ferritin, procalcitonin, LDH, CRP, cytokine panel f. Troponin, cardiac enzymes 10. Requirement for respiratory support a. New supplemental oxygen requirement (FIO2 and mode of delivery) b. Requirement for mechanical ventilation (include mode and settings, Pplat if available) c. Requirement for ECMO d. Use of prone positioning, inhaled nitric oxide 11. Requirement for new renal replacement therapy 12. Glasgow Coma Scale (GCS) 13. AVPU Scale (alert, verbal, pain, unresponsive) 14. Sequential Organ Failure Assessment Score (SOFA)